Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2016-11-07 Declaration of Voting R…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in major shareholdings ('Notification of Major Holdings') by an entity (Ministry of Finance on behalf of the State of Norway) in STADA Arzneimittel AG, referencing German Securities Trading Act (WpHG) sections (Art. 26, Sec. 1, Sec. 21, Sec. 22, Sec. 25). This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2016-11-07 English
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'DGAP Voting Rights Announcement' and contains sections detailing 'Notification of Major Holdings,' including changes in the percentage of voting rights held by a shareholder (Ministry of Finance on behalf of the State of Norway/Norges Bank). This directly corresponds to the definition of a Voting Rights Announcement, which is a specific type of regulatory disclosure concerning share ownership thresholds. Although it involves major shareholding changes, the primary classification based on the document's explicit title and content structure is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not a general regulatory filing (RNS) because DVA is more specific, nor is it a Major Shareholding Notification (MRQ) which typically refers to the notification *by* the shareholder crossing the threshold, whereas this document is framed as the official announcement of that event, often related to a general meeting context or regulatory requirement.
2016-11-07 English
Datum:07.10.2016
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from STADA Arzneimittel AG regarding the dividend distribution decision made at the Annual General Meeting held on August 26, 2016. It specifies the dividend amount per share and the total payout, which fits the definition of a Notice of Dividend Amount.
2016-10-07 German
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'DGAP Voting Rights Announcement' and contains sections detailing the 'Notification of Major Holdings,' including changes in voting rights percentages (e.g., previous notification 3.32% vs. resulting situation 2.94%) and the shareholder involved (Ministry of Finance on behalf of the State of Norway). This content directly corresponds to regulatory filings concerning changes in significant share ownership thresholds. While 'Major Shareholding Notification' (MRQ) is a possibility, the document header explicitly mentions 'Voting Rights Announcements' and the structure aligns perfectly with regulations requiring disclosure of voting rights changes, which is covered by the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) definition, or more generally, 'Major Shareholding Notification' (MRQ). Given the specific focus on voting rights percentage changes crossing thresholds, MRQ (Major Shareholding Notification) is the most precise fit among the provided options, as DVA usually refers to the *results* of a vote, not the ongoing change in ownership stake.
2016-09-30 English
DGAP-DD: STADA Arzneimittel AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains structured information detailing a transaction ('Geschäfte von Personen, die Führungsaufgaben wahrnehmen') by a member of the Supervisory Board ('Aufsichtsrat') of STADA Arzneimittel AG. Section 4 details the 'Art des Geschäfts' (Type of transaction) as 'Kauf' (Buy) involving shares. This directly corresponds to the definition of Director's Dealing reports.
2016-09-30 German
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcement' and contains sections detailing the 'Notification of Major Holdings' under German securities law (WpHG). It reports changes in voting rights percentages (e.g., from 1.39% to 3.32%) held by Norges Bank in STADA Arzneimittel AG. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The code for this is MRQ.
2016-09-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.